Related Experiment Video
Updated: Aug 1, 2026

An Analytical Tool that Quantifies Cellular Morphology Changes from Three-dimensional Fluorescence Images
Published on: August 31, 2012
Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1)
B D Reilly1, S C Makrides, P J Ford
1University of New Mexico School of Medicine, Albuquerque 87131.
Insights
Complement receptor 1 (CR1) binds C4b2 dimers via its short consensus repeats (SCRs) 1-4. These SCRs are crucial for CR1
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Complement receptor 1 (CR1/CD35) is a transmembrane protein with extracellular short consensus repeats (SCRs).
- CR1's structure includes four long homologous repeats (LHRs), each containing binding sites for complement fragments C3b and C4b.
Purpose of the Study:
- To analyze the binding of CR1 to soluble C4b2 dimers.
- To identify the specific SCRs within LHR-A responsible for C4b2 binding.
- To investigate if C3b binding sites on CR1 can also bind C4b2.
Main Methods:
- Utilized native CR1 on human erythrocytes and recombinant full-length CR1 expressed in Chinese hamster ovary (CHO) cells.
- Employed CR1 mutants to map C4b2 binding sites.
- Measured binding affinities (Kd) of CR1 constructs to C4b2.
Main Results:
- CR1, full-length CR1 (ABCD), ACD, and SCR(1-4)D constructs bound C4b2 with similar high affinity (Kd ≈ 4 x 10⁻⁷ M).
- SCR(1-2)D showed lower affinity (Kd = 1.4 x 10⁻⁶ M), indicating SCRs 1-4 are essential for optimal C4b2 binding.
- SCR(15-18)D, a C3b binding site, exhibited lower affinity for C4b2 (Kd = 1.2 x 10⁻⁶ M).
- CR1 constructs binding C4b2 also acted as cofactors for factor I-mediated C4d cleavage.
Conclusions:
- The N-terminal SCRs (1-4) of CR1 are critical for high-affinity C4b2 binding.
- While C3b binding sites can weakly bind C4b2, the primary binding site is distinct and located within the first four SCRs.
- CR1's ability to bind C4b2 and facilitate its cleavage is essential for complement regulation.
Abstract:
The complement receptor CR1 (CD35) is a transmembrane protein composed in its extracellular portion of short consensus repeats (SCR 1-30) organized into four long homologous repeats (LHR-A, LHR-B, LHR-C, and LHR-D). Each LHR, except LHR-D, contains a binding site for C3b and/or C4b within its first four SCR. The binding reaction between CR1 and soluble dimers of C4b (C4b2) was analyzed using the native receptor on human erythrocytes and full-length recombinant CR1 expressed in stably transfected Chinese hamster ovary (CHO) cells. CR1 mutants expressed similarly were used to determine the SCR of LHR-A required for C4b2 binding and the potential of C3b binding sites in CR1 to bind C4b2. Erythrocyte CR1, CHO cells expressing full-length recombinant CR1 (ABCD), constructs ACD, and SCR(1-4)D each bound C4b2 with similar affinities (Kd, approximately 4 x 10(-7) M). Construct SCR(1-2)D bound C4b2 with lower affinity (Kd, 1.4 x 10(-6) M) indicating that SCR(1-4) are required for a fully functional C4b2 binding site. Construct SCR(15-18)D, which contains a C3b site, also bound C4b2 with lower affinity (Kd 1.2 x 10(-6) M) than its binding to C3b dimers. Constructs SCR(15-16)D and D did not bind C4b2. Each CR1 construct that bound C4b2 functioned as a cofactor for factor I-mediated cleavage to C4d.

